-
admin
Posts
Desire of Chinese, American people to reach out to each other is simple, sincere: Global Times editorial
BEIJING, March 28, 2025 /PRNewswire/ — Recently, an American YouTube sensation known as “IShowSpeed,” who has 37 million followers on the platform, has streamed his...
Vobile Unveils DreamMaker: AI-Powered Creative Platform with Copyright Protection and Monetization
SANTA CLARA, Calif., March 28, 2025 /PRNewswire/ — Vobile, a worldwide leader in digital content protection and transaction services, today announced the launch of DreamMaker,...
Apacer Sets a New Standard with Fully Lead-Free DDR5 Solutions for a Greener Tomorrow
TAIPEI, March 28, 2025 /PRNewswire/ — Apacer Technology Inc. (8271), a global leader in digital storage solutions, today announced that in response to increasingly stringent...
EPSIUM ENTERPRISE LIMITED Announces Closing of US$5.0 Million Initial Public Offering
MACAU, March 28, 2025 /PRNewswire/ — EPSIUM ENTERPRISE LIMITED (Nasdaq: EPSM) (the “Company” or “EPSIUM”), a company engaged in importing and wholesaling primarily alcoholic beverages...
Supermicro Ships Over 20 New Systems that Redefine Single-Socket Performance and Deliver Data Center Power, Space, and Cost Savings
New system architectures support Intel® Xeon® 6 with P-Cores, providing up to 136 PCIe 5.0 lanes and expanding possibilities for high-speed networking, GPUs, and storage devices ...
Chitin Market Research Report 2025: Analysis and Forecast Through 2020-2030, Featuring Profiles of Sfly, Heppe Medical Chitosan, Golden-Shell Pharmaceutical, Zhejiang Fengrun Biotech, and Aoxin Biotechnology
Dublin, March 27, 2025 (GLOBE NEWSWIRE) — The “Chitin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application” report has...
Evaxion to announce business update and full year 2024 financial results on April 1, 2025
COPENHAGEN, Denmark, March 27, 2025 – Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a...
4DMT to Participate in Upcoming Investor Conferences
EMERYVILLE, Calif., March 27, 2025 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and...
TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after Chemotherapy
Media Release COPENHAGEN, Denmark; March 27, 2025 TIVDAK® is the first and only antibody-drug conjugate (ADC) approved for patients with advanced or recurrent cervical cancer...
New Data to Be Presented at Upcoming Congresses Showcase Cerevance’s Advanced Clinical Program in Parkinson’s Disease and Deep Pipeline for CNS-based Disorders
Topline results from Phase 2 ASCEND trial of solengepras as a monotherapy treatment for early-stage Parkinson’s to be presented First presentation of data from Phase...
